Pacific Biosciences of California, Inc.(PACB)

Research Snapshot

Pacific Biosciences of California, Inc. (PACB) is a Healthcare stock with a market cap of $480.00M and listed on NASDAQ. The stock last traded around $1.60 and up 4.7% across the available one-year price window (Jun 26, 2025 → Jun 16, 2026). Baseline metrics include revenue growth of +3.9%, EPS growth of -61.1%, a dividend yield of 0.0%. What stands out right now is revenue +3.9%, EPS -61.1%, free cash flow +46.3% with operating margin -346.1% and ROIC -75.9%. Valuation is more restrained than many high-expectation growth names at price/sales 3.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines PACB price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.